Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
How a Harvard Doctor Built Robyn, an AI Partner for Emotional Support
During the pandemic, psychiatrist and Harvard resident Jenny Shao observed a troubling pattern: the isolation sweeping across society was triggering neurological changes and deepening people’s emotional struggles. Rather than continue treating symptoms in her clinical role, Shao made a bold decision to pivot into entrepreneurship. Her mission was clear—create an AI partner that could offer genuine emotional understanding to those navigating loneliness and disconnection. That venture became Robyn, an emotionally intelligent digital companion designed to truly listen and remember.
The landscape of AI companions has become increasingly crowded. Beyond general chatbots like ChatGPT, there’s a thriving ecosystem of apps explicitly focused on friendship and companionship—Character.AI, Replika, Friend—and wellness-focused tools like Feeling Great. Research revealed that 72% of American teenagers have experimented with these AI partner apps, though some have drawn scrutiny and legal challenges for their role in vulnerable situations. This complexity underscores why Shao’s positioning of Robyn matters so much.
Robyn as a Thoughtful Partner, Not a Therapist
Shao is explicit about what Robyn is and isn’t. “From my experience as a doctor, I’ve witnessed negative outcomes when tech companies attempt to take the place of physicians. Robyn is not, and will never be, a clinical substitute,” she explained to TechCrunch. Instead, she describes it as an AI partner that acts like someone who deeply understands you—a confidant rather than a clinician. The distinction is crucial for both ethical clarity and user expectations.
When you first open Robyn on iOS, you encounter a familiar onboarding flow reminiscent of meditation or journaling apps. Users share details about themselves, their goals, how they cope with adversity, and their preferred conversational tone. This initial setup serves a purpose beyond personalization—it’s foundational data for the app’s most distinctive feature.
Emotional Intelligence Meets Memory
Shao previously conducted groundbreaking research on human memory in Eric Kandel’s lab. Kandel, who won the Nobel Prize in Physiology or Medicine in 2000, studied how memories form and persist. Shao applied those neuroscientific insights directly into Robyn’s architecture, enabling the AI partner to develop a nuanced understanding of each user over time. As interactions accumulate, Robyn generates insights into emotional patterns, attachment styles, communication preferences, areas for personal growth, and even the user’s inner critic.
This emotional profiling extends beyond conversations. The company developed a demo website that analyzes X profiles to illustrate the depth of reflection Robyn can offer—it doesn’t just respond to what you say today, it understands who you are across dimensions.
Building Safeguards into the Robyn Partner Experience
Given the sensitive nature of emotional support, safety mechanisms aren’t an afterthought—they’re embedded. If someone mentions self-harm, Robyn immediately provides a crisis hotline number and navigation to the nearest emergency room. The AI also enforces gentle boundaries: if asked for sports scores or other off-topic requests, it politely declines and redirects toward personal reflection instead.
These guardrails reflect Shao’s medical training and her conviction that powerful technology requires responsible deployment. The stakes are real, which is why the company didn’t rush from pilot to public launch.
Investor Confidence and Market Traction
The market took notice. Robyn raised $5.5 million in seed funding led by M13, with backing from an impressive coalition of technology insiders. The group includes Lars Rasmussen, co-founder of Google Maps; Bill Tai, an early investor in Canva; Ken Goldman, former CFO of Yahoo; and Christian Szegedy, co-founder of X.ai. Their participation signals confidence not just in the product, but in Shao’s judgment about how AI should interact with human wellbeing.
The team expanded from three founders at the start of 2025 to ten members today, enabling faster development and a more ambitious roadmap. Lars Rasmussen articulated the broader vision: “We’re facing a significant issue of disconnection. Despite being surrounded by technology, people often feel less understood. Robyn directly addresses this by helping individuals reflect, identify their own patterns, and reconnect with themselves.”
The Challenge Ahead
For all its promise, Robyn’s success hinges on maintaining user trust and preventing unhealthy emotional attachment to an AI. Latif Parecha, a partner at M13, acknowledged this tension: “There must be protocols for escalation in situations where someone is truly at risk. Especially as AI becomes as integrated into our lives as family and friends.” It’s a reminder that even the most thoughtfully designed AI partner requires human oversight.
The company completed months of limited testing and is now rolling out across the U.S. market. The service operates on a subscription model: $19.99 per month or $199 annually. Whether Robyn can sustain the careful balance between companionship and clinical responsibility remains the defining question—but early indicators suggest Shao’s medical background and commitment to ethics may make all the difference in building an AI partner the world actually needs.